Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

2.12
-0.0500-2.30%
Post-market: 2.09-0.0300-1.42%18:59 EDT
Volume:687.18K
Turnover:1.47M
Market Cap:77.75M
PE:-0.68
High:2.18
Open:2.18
Low:2.09
Close:2.17
Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
8 hours ago

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Rises 5.0%, Outperforms Competitors

Dow Jones
·
03 Jun

Inovio Pharmaceuticals Inc. Stock Sheds 6.1%, Underperforms Competitors

Dow Jones
·
31 May

Inovio Pharmaceuticals Inc. Stock Advances 6.5%, Outperforms Competitors

Dow Jones
·
30 May

Inovio Pharmaceuticals Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
28 May

Inovio Pharmaceuticals Holds Annual Stockholders Meeting

TIPRANKS
·
23 May

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
22 May

Inovio Pharmaceuticals Inc. Stock Rallies 2.9%, Outperforms Competitors

Dow Jones
·
21 May

Inovio Pharmaceuticals Inc. Stock Rises 5.1%, Outperforms Competitors

Dow Jones
·
17 May

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
15 May

Inovio Pharma Price Target Maintained With a $5.00/Share by RBC Capital

Dow Jones
·
14 May

Inovio Pharma Is Maintained at Outperform by Oppenheimer

Dow Jones
·
14 May

Oppenheimer Adjusts Inovio Pharmaceuticals Price Target to $13 From $15, Maintains Outperform Rating

MT Newswires Live
·
14 May

Inovio Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Inovio Pharmaceuticals Q1 EPS $(0.51) Up From $(1.31) YoY, Sales $65.34K Up from 0 YoY

Benzinga
·
14 May

BRIEF-Inovio Pharmaceuticals Q1 Operating Expenses USD 25.1 Million

Reuters
·
14 May

Inovio Pharmaceuticals Reports Reduced Net Loss of $19.7 Million, EPS Improves to $0.51 for Q1 2025

Reuters
·
14 May

Inovio Pharmaceuticals Inc: Cash, Cash Equivalents and Short-Term Investments Balances to Support Company's Operations Into Q1 of 2026

THOMSON REUTERS
·
14 May

Inovio Pharmaceuticals Q1 EPS USD -0.51

THOMSON REUTERS
·
14 May